Binex Quality Issues Suggest Bigger Generic Problems In Korea?
Co-BE Test System In Spotlight
Executive Summary
A slew of recent manufacturing issues at several Korean pharma firms have prompted calls for improved quality control at and a change in the country's co-bioequivalence study system for generics.
You may also be interested in...
Korea To Toughen Co-Bioequivalence Study System
Legislation that could thin the crowded generic market clears first parliamentary hurdle as brand and generic firms alike react to the recent generic quality issue raised by recent manufacturing incidences at some South Korean pharma firms.
Korea To Toughen Co-Bioequivalence Study System Amid Generic Quality Issue
Legislation that could thin the crowded generic market clears first parliamentary hurdle as brand and generic firms alike react to the recent generic quality issue raised by recent manufacturing incidences at some South Korean pharma firms.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.